How can gene therapy address diseases caused by a dominant negative mutation (where a mutant gene product interferes with normal function)?
Show answer and explanation
Correct answer: By silencing or knocking down the mutant allele's expression
In dominant-negative disorders, silencing the mutant allele (e.g. via RNA interference or gene disruption) suppresses the harmful product's interference with normal function — an established gene therapy approach.
Keep practicing
More Gene therapy basics questions
- Which statement about non-viral gene delivery systems is correct compared to viral vectors?
- Which gene therapy approach could potentially treat a recessive loss-of-function genetic disease by restoring missing protein function?
- Which of the following is an advantage of using in vivo gene therapy over ex vivo gene therapy?
- Why is immune response a major concern in gene therapy using viral vectors?
- What is the primary goal of gene therapy?
- Which of the following is the most common type of delivery vector used in gene therapy?